The authors explicitly state it remains incompletely characterized whether GLP-1 RAs consistently engage neural circuits underlying cognition and psychopathology. This knowledge gap limits translation of promising preclinical neuroprotective effects to clinical applications in Alzheimer's and Parkinson's disease. Gap type: open_question Source paper: Are Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Central Nervous System (CNS) Penetrant: A Narrative Review. (2025, Neurology and therapy, PMID:40172827)
Landscape Summary: Do GLP-1 RAs reproducibly engage neural targets that mediate cognitive functions in humans? is a 0.82 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
Do GLP-1 RAs reproducibly engage neural targets that mediate cognitive functions in humans? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: